Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.5375
+0.0068 (1.28%)
At close: Jan 6, 2026, 4:00 PM EST
0.5410
+0.0035 (0.65%)
After-hours: Jan 6, 2026, 7:46 PM EST
Cosmos Health Employees
Cosmos Health had 149 employees as of December 31, 2024. The number of employees increased by 26 or 21.14% compared to the previous year.
Employees
149
Change (1Y)
26
Growth (1Y)
21.14%
Revenue / Employee
$401,294
Profits / Employee
-$124,444
Market Cap
18.77M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 149 | 26 | 21.14% |
| Dec 31, 2023 | 123 | 21 | 20.59% |
| Dec 31, 2022 | 102 | 7 | 7.37% |
| Dec 31, 2021 | 95 | 6 | 6.74% |
| Dec 31, 2020 | 89 | 18 | 25.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COSM News
- 1 day ago - Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units - GlobeNewsWire
- 13 days ago - Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy - Accesswire
- 18 days ago - Cosmos Health is Forcing the Market to Reframe the Conversation - Accesswire
- 4 weeks ago - Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets - GlobeNewsWire
- 5 weeks ago - Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases - GlobeNewsWire
- 7 weeks ago - Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M - GlobeNewsWire
- 2 months ago - Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy - GlobeNewsWire
- 2 months ago - Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million - GlobeNewsWire